NeuroMetrix, Inc. Announces Date for Second Quarter 2023 Business and Financial Highlights Conference Call
20 Julho 2023 - 2:00PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its Q2 2023 business and financial highlights before the
opening of the market on July 27, 2023. The Company will host a
conference call at 8:00 a.m., Eastern Time on July 27, 2023.
For participants who wish to access the Q2 2023 Conference Call
live via telephone and be able to ask questions, please register in
advance here. Upon registering, a dial-in and unique PIN will be
provided on screen and via email to join the call. An audio-only
webcast of the call, along with the earnings press release and
accompanying condensed financial statements, may be accessed in the
Investors section of the Company’s website at www.NeuroMetrix.com.
Following the conference call, a replay of the call will be
available for one year on the Company's Investors section of the
website.
About NeuroMetrix
NeuroMetrix is a commercial stage healthcare company that
develops and commercializes neurotechnology devices to address
unmet needs in the chronic pain and diabetes markets. The Company's
products are wearable or hand-held medical devices enabled by
proprietary consumables and software solutions that include mobile
apps, enterprise software and cloud-based systems. The Company has
two commercial brands. Quell® is a wearable neuromodulation
platform. DPNCheck® is a point-of-care screening test for
peripheral neuropathy. For more information, visit
www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. HigginsSVP and Chief Financial
Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
NeuroMetrix (NASDAQ:NURO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024